Eur J Cancer2023 Aug.
進行膵癌患者を対象としたmFOLFIRINOX+ramucirumab療法とmFOLFIRINOX+プラセボ療法の第Ⅱ相無作為化二重盲検比較試験(HCRN GI14-198)
Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).
Shaib WL, Manali R, Liu Y, El-Rayes B, Loehrer P, O'Neil B, Cohen S, Khair T, Robin E, Huyck T, Bekaii-Saab T